TECTONIC THERAPEUTIC, INC. Increase Decrease In Operating Lease Liability
TECTONIC THERAPEUTIC, INC. (TECX) reported Increase Decrease In Operating Lease Liability of -$285.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- TECTONIC THERAPEUTIC, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$138.00K.
- TECTONIC THERAPEUTIC, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$147.00K.
- TECTONIC THERAPEUTIC, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$593.00K, a 236.64% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$581.00K.
- TECTONIC THERAPEUTIC, INC. increase decrease in operating lease liability for fiscal 2025 was -$2.29M.
- TECTONIC THERAPEUTIC, INC. increase decrease in operating lease liability for fiscal 2024 was -$565.00K.
- TECTONIC THERAPEUTIC, INC. increase decrease in operating lease liability for fiscal 2023 was -$950.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$285.00K 10-Q · filed 2026-08-06 | -$878.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$147.00K 10-Q · filed 2026-05-07 | -$740.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.32M derived: sum of 3 quarters · filed 2026-05-07 | -$1.89M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$593.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.17M derived: sum of 2 quarters · filed 2026-02-26 | -$1.74M derived: sum of 3 quarters · filed 2026-08-06 | -$2.29M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$581.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.15M derived: sum of 2 quarters · filed 2026-08-06 | -$1.70M 10-Q · filed 2025-11-06 | -$1.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$568.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.12M 10-Q · filed 2026-08-06 | -$687.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$553.00K 10-Q · filed 2026-05-07 | -$119.00K derived: sum of 2 quarters · filed 2026-05-07 | -$460.00K derived: sum of 3 quarters · filed 2026-05-07 | -$794.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $434.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $93.00K derived: sum of 2 quarters · filed 2026-02-26 | -$241.00K derived: sum of 3 quarters · filed 2026-02-26 | -$565.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$341.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$675.00K derived: sum of 2 quarters · filed 2025-11-06 | -$999.00K 10-Q · filed 2025-11-06 | -$1.31M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$334.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$658.00K 10-Q · filed 2025-08-07 | -$968.00K derived: sum of 3 quarters · filed 2025-08-07 | -$1.27M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$324.00K 10-Q · filed 2025-05-08 | -$634.00K derived: sum of 2 quarters · filed 2025-05-08 | -$938.00K derived: sum of 3 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$614.00K derived: sum of 2 quarters · filed 2025-03-20 | -$950.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | -$304.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$640.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$336.00K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |